136 related articles for article (PubMed ID: 9562602)
41. Nanomolar small molecule inhibitors for alphav(beta)6, alphav(beta)5, and alphav(beta)3 integrins.
Goodman SL; Hölzemann G; Sulyok GA; Kessler H
J Med Chem; 2002 Feb; 45(5):1045-51. PubMed ID: 11855984
[TBL] [Abstract][Full Text] [Related]
42. N-acyl phenylalanine analogues as potent small molecule VLA-4 antagonists.
Chen L; Tilley JW; Huang TN; Miklowski D; Trilles R; Guthrie RW; Luk K; Hanglow A; Rowan K; Schwinge V; Wolitzky B
Bioorg Med Chem Lett; 2000 Apr; 10(8):725-7. PubMed ID: 10782673
[TBL] [Abstract][Full Text] [Related]
43. Disubstituted indazoles as potent antagonists of the integrin alpha(v)beta(3).
Batt DG; Petraitis JJ; Houghton GC; Modi DP; Cain GA; Corjay MH; Mousa SA; Bouchard PJ; Forsythe MS; Harlow PP; Barbera FA; Spitz SM; Wexler RR; Jadhav PK
J Med Chem; 2000 Jan; 43(1):41-58. PubMed ID: 10633037
[TBL] [Abstract][Full Text] [Related]
44. [Anti-adhesive and anti-thrombotic effects of integrin-inhibiting tripeptides (Arg-Gly-Asp)].
Udvardy M
Orv Hetil; 1995 Oct; 136(40):2155-9. PubMed ID: 7566948
[TBL] [Abstract][Full Text] [Related]
45. N-acyl-L-phenylalanine derivatives as potent VLA-4 antagonists that mimic a cyclic peptide conformation.
Chen L; Tilley J; Trilles RV; Yun W; Fry D; Cook C; Rowan K; Schwinge V; Campbell R
Bioorg Med Chem Lett; 2002 Jan; 12(2):137-40. PubMed ID: 11755339
[TBL] [Abstract][Full Text] [Related]
46. Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis model.
Miller WH; Bondinell WE; Cousins RD; Erhard KF; Jakas DR; Keenan RM; Ku TW; Newlander KA; Ross ST; Haltiwanger RC; Bradbeer J; Drake FH; Gowen M; Hoffman SJ; Hwang SM; James IE; Lark MW; Lechowska B; Rieman DJ; Stroup GB; Vasko-Moser JA; Zembryki DL; Azzarano LM; Adams PC; Huffman WF
Bioorg Med Chem Lett; 1999 Jul; 9(13):1807-12. PubMed ID: 10406646
[TBL] [Abstract][Full Text] [Related]
47. New orally active non-peptide fibrinogen receptor (GpIIb-IIIa) antagonists: identification of ethyl 3-[N-[4-[4-[amino[(ethoxycarbonyl) imino]methyl]phenyl]-1,3-thiazol-2-yl]-N-[1-[(ethoxycarbonyl)methyl]pip erid -4-yl]amino]propionate (SR 121787) as a potent and long-acting antithrombotic agent.
Badorc A; Bordes MF; de Cointet P; Savi P; Bernat A; Lalé A; Petitou M; Maffrand JP; Herbert JM
J Med Chem; 1997 Oct; 40(21):3393-401. PubMed ID: 9341914
[TBL] [Abstract][Full Text] [Related]
48. Small molecule alpha(v) integrin antagonists: novel anticancer agents.
Kerr JS; Slee AM; Mousa SA
Expert Opin Investig Drugs; 2000 Jun; 9(6):1271-9. PubMed ID: 11060742
[TBL] [Abstract][Full Text] [Related]
49. Squaric acid derivatives as VLA-4 integrin antagonists.
Porter JR; Archibald SC; Childs K; Critchley D; Head JC; Linsley JM; Parton TA; Robinson MK; Shock A; Taylor RJ; Warrellow GJ; Alexander RP; Langham B
Bioorg Med Chem Lett; 2002 Apr; 12(7):1051-4. PubMed ID: 11909715
[TBL] [Abstract][Full Text] [Related]
50. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation.
Cook JJ; Sitko GR; Holahan MA; Stranieri MT; Glass JD; Askew BC; McIntyre CJ; Claremon DA; Baldwin JJ; Hartman GD; Gould RJ; Lynch JJ
J Pharmacol Exp Ther; 1997 May; 281(2):677-89. PubMed ID: 9152373
[TBL] [Abstract][Full Text] [Related]
51. Clues for understanding the structure and function of a prototypic human integrin: the platelet glycoprotein IIb/IIIa complex.
Calvete JJ
Thromb Haemost; 1994 Jul; 72(1):1-15. PubMed ID: 7974356
[TBL] [Abstract][Full Text] [Related]
52. Anti-integrin as novel drug-discovery targets: potential therapeutic and diagnostic implications.
Mousa SA
Curr Opin Chem Biol; 2002 Aug; 6(4):534-41. PubMed ID: 12133730
[TBL] [Abstract][Full Text] [Related]
53. In vivo therapy of malignant melanoma by means of antagonists of alphav integrins.
Mitjans F; Meyer T; Fittschen C; Goodman S; Jonczyk A; Marshall JF; Reyes G; Piulats J
Int J Cancer; 2000 Sep; 87(5):716-23. PubMed ID: 10925366
[TBL] [Abstract][Full Text] [Related]
54. Nonpeptide alpha(v)beta(3) antagonists. Part 2: constrained glycyl amides derived from the RGD tripeptide.
Meissner RS; Perkins JJ; Duong LT; Hartman GD; Hoffman WF; Huff JR; Ihle NC; Leu CT; Nagy RM; Naylor-Olsen A; Rodan GA; Rodan SB; Whitman DB; Wesolowski GA; Duggan ME
Bioorg Med Chem Lett; 2002 Jan; 12(1):25-9. PubMed ID: 11738566
[TBL] [Abstract][Full Text] [Related]
55. Disintegrins: RGD-containing proteins which inhibit cell/matrix interactions (adhesion) and cell/cell interactions (aggregation) via the integrin receptors.
Williams JA
Pathol Biol (Paris); 1992 Oct; 40(8):813-21. PubMed ID: 1484742
[TBL] [Abstract][Full Text] [Related]
56. Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine Gly-Asp mimetic.
Miller WH; Alberts DP; Bhatnagar PK; Bondinell WE; Callahan JF; Calvo RR; Cousins RD; Erhard KF; Heerding DA; Keenan RM; Kwon C; Manley PJ; Newlander KA; Ross ST; Samanen JM; Uzinskas IN; Venslavsky JW; Yuan CC; Haltiwanger RC; Gowen M; Hwang SM; James IE; Lark MW; Rieman DJ; Stroup GB; Azzarano LM; Salyers KL; Smith BR; Ward KW; Johanson KO; Huffman WF
J Med Chem; 2000 Jan; 43(1):22-6. PubMed ID: 10633035
[No Abstract] [Full Text] [Related]
57. Solid-phase synthesis of dual alpha4beta1/alpha4beta7 integrin antagonists: two scaffolds with overlapping pharmacophores.
Castanedo GM; Sailes FC; Dubree NJ; Nicholas JB; Caris L; Clark K; Keating SM; Beresini MH; Chiu H; Fong S; Marsters JC; Jackson DY; Sutherlin DP
Bioorg Med Chem Lett; 2002 Oct; 12(20):2913-7. PubMed ID: 12270174
[TBL] [Abstract][Full Text] [Related]
58. Specific and dual antagonists of alpha(4)beta(1) and alpha(4)beta(7) integrins.
Lin LS; Lanza T; McCauley E; Van Riper G; Kidambi U; Cao J; Egger LA; Mumford RA; Schmidt JA; MacCoss M; Hagmann WK
Bioorg Med Chem Lett; 2002 Jan; 12(2):133-6. PubMed ID: 11755338
[TBL] [Abstract][Full Text] [Related]
59. Synthesis of a peptidomimetic tricyclic tetrahydrobenzo[ij]quinoline as a VLA-4 antagonist.
Ho WB; Broka C
J Org Chem; 2000 Oct; 65(20):6743-8. PubMed ID: 11052128
[No Abstract] [Full Text] [Related]
60. Design, synthesis and biological evaluation of nonpeptide integrin antagonists.
Nicolaou KC; Trujillo JI; Jandeleit B; Chibale K; Rosenfeld M; Diefenbach B; Cheresh DA; Goodman SL
Bioorg Med Chem; 1998 Aug; 6(8):1185-208. PubMed ID: 9784861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
